Course of upper eyelid retraction in thyroid eye disease.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
02 2020
Historique:
received: 16 11 2018
revised: 25 02 2019
accepted: 13 04 2019
pubmed: 13 5 2019
medline: 18 7 2020
entrez: 13 5 2019
Statut: ppublish

Résumé

To evaluate the natural course of upper eyelid retraction (UER) in patients with thyroid eye disease (TED) and factors affecting its course. Retrospective non-interventional cohort study in a single tertiary institution from March 2006 to March 2015 on patients with TED with (1) unilateral or bilateral UER within 6 months from initial presentation, and (2) no prior interventions nor surgical treatment for their UER. Main outcomes and measures were mean margin reflex distance 1 (MRD1) and factors associated with UER improvement. There were a total of 61 patients and 81 eyes (41 unilateral and 20 bilateral UER). Mean age was 42.3±15.1 years. Mean MRD1 decreased from 6.1 mm at presentation to 4.8 mm at 12 months, and 4.4 mm at 24 months. The proportion of eyes with normalisation of lid height increased from 0% at presentation to 22.2% at 6 months, 37.0% at 12 months and 49.4% at 24 months. Mean time to normalisation of MRD1 was 18.0±12.4 months. A positive family history of TED was found to be associated with a 6.2 times lower likelihood of normalisation. Change in exophthalmometry, clinical activity score and thyroid-stimulating immunoglobulin were significantly correlated to change in MRD1 (p<0.05). There was no correlation between change in MRD1 and thyroid-stimulating hormone receptor antibodies. An improved knowledge of the natural history of UER in TED will allow us to better decide and evaluate the optimal management for such patients.

Identifiants

pubmed: 31079052
pii: bjophthalmol-2018-313578
doi: 10.1136/bjophthalmol-2018-313578
doi:

Substances chimiques

Immunoglobulins, Thyroid-Stimulating 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-259

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Dong Cheol Lee (DC)

Department of Ophthalmology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea.

Stephanie M Young (SM)

Ophthalmology, National University Health System, Singapore, Singapore.

Yoon-Duck Kim (YD)

Ophthalmology, Samsung Medical Center, Seoul, South Korea yoonduck.kim@samsung.com.

Kyung In Woo (KI)

Ophthalmology, Samsung Medical Center, Seoul, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH